Key result
Drug-eluting stents significantly reduced rates of restenosis compared to bare-metal stents in percutaneous coronary intervention.
Biodegradable polymer ultrathin drug-eluting stents represent a new stage of safety and efficacy in percutaneous coronary intervention.
The introduction of drug-eluting stent (DESs) revolutionized percutaneous coronary intervention (PCI) by significantly reducing rates of restenosis compared to bare-metal stents.
No takes yet. Share an insight, caveat, or question.
Cocco et al. (2024) studied this question. Drug-eluting stents significantly reduced rates of restenosis compared to bare-metal stents in percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: